Unknown

Dataset Information

Interleukin-6 receptor blockade improves bone healing following ischemic osteonecrosis in adolescent mice.


ABSTRACT:

Objective

Juvenile ischemic osteonecrosis (JIO) of the femoral head is one of the most serious hip disorders causing a permanent deformity of the femoral head in childhood. We recently reported that interleukin 6 (IL-6) is significantly increased in the hip synovial fluid of patients with JIO and that articular chondrocytes are primary source of IL-6. Adolescent JIO is particularly challenging to treat and has poor outcome. This study determined if IL-6 receptor blockade prevents bone loss and improves the bone healing in adolescent JIO.

Method

Adolescent mice (12-week-old) surgically induced with JIO were treated with either saline or MR16-1, an IL-6 receptor blocker.

Results

Micro-CT assessment showed significantly increased bone volume (p ​< ​0.001, Cohen's

SUBMITTER: Kuroyanagi G 

PROVIDER: S-EPMC10432805 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature